✦ LIBER ✦

Paclitaxel + carboplatin + gemcitabine for ovarian cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot study of outpatient paclitaxel, ca

✍ John P. Micha; Bram H. Goldstein; Mark A. Rettenmaier; Julie Mattison; Cheri Gra 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Phase II study of carboplatin followed b

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

A phase II feasibility study of carbopla

✍ Harries, M; Moss, C; Perren, T; Gore, M; Hall, G; Everard, M; A'Hern, R; Gibbens 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

Dose intense triplet chemotherapy with g

✍ Barlow, C; Nystrom, M; Oesterling, C; Fennell, D; Ismay, J; Gallagher, C 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

First-line therapy for ovarian cancer wi

✍ Roshan Agarwal; Charlie Gourley; Timothy J. Perren; Nicholas Reed; David E. Park 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 361 KB

Gemcitabine and oxaliplatin followed by

✍ C.B. Steer; K. Chrystal; K.A. Cheong; E. Galani; G.M. Marx; A.H. Strickland; D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB